Chinese Academy of Sciences’ Investment Management unit put up a share of the proceeds for health insurance data analytics company Leyue Health’s series B round.

China-based patient data provider Leyue Health obtained RMB115m ($16.1m) on Thursday in a Cowin Capital-led series B round backed by CAS Investment Management, a subsidiary of Chinese Academy of Sciences.
Founded in 2014 and officially named Shanghai Leyue Information Technology, the company operates a big data-driven platform enabling insurance providers to access patient data held by hospitals and medical centres in order to facilitate claims, underwriting and other industry obligations.
Leyue Health’s data library pools information from 3,254…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?